A divided Arizona Supreme Court upheld a state law that limits liability to bars and restaurants for damages caused by intoxicated patrons, overturning a
The Supreme Court on Thursday ruled against the drug company Amgen, which had sued Sanofi for infringing Amgen’s patent on antibodies that lower LDL cholesterol, sometimes called “bad” cholesterol. Amgen’s patent is invalid, the court found, because it fails to provide enough information to enable o
During oral argument in Amgen Inc. v. Sanofi on Monday, the justices explored how to write an opinion on patent enablement when the parties agree on almost everything about the legal standard. “Enablement” is the requirement that a patent must enable others to make and use the invention without un
Two pharmaceutical giants head to the Supreme Court on Monday in a dispute over a patent covering cholesterol-lowering antibodies. In Amgen Inc. v. Sanofi, the justices will consider whether Amgen’s patent is too broad to be valid under federal patent rules. Amgen has patents on monoclonal antibo